Schedule Notes: This lawsuit is about a woman who took Invokana and developed ketoacidosis. The first half of the article should include details about the lawsuit; the second half should include background information about this side effect.
Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, is being hit with an Invokana lawsuit from a woman who claimed the drug had caused her irreparable damages.
According to the claim, the woman had developed Invokana ketoacidosis in direct result of the type-2 diabetes medication. Alabama plaintiff Luana C. had been prescribed Invokana in December 2014, to help manager her type-2 diabetes symptoms.
In particular, Luana had opted for Invokana to reduce the levels of her blood-glucose and would have helped her live a healthier and more active lifestyle. Unfortunately it was not long after Luana had been prescribed Invokana, that she developed severe complications that ultimately made her condition worse.
According to her lawsuit Luana had developed Invokana ketoacidosis, which makes her unable to produce insulin. Luana states that she had developed this injury, in direct result of Janssen’s failure to warn her of the drug’s side effects.
Luana claims in her Invokana lawsuit that if she had known about the risk of ketoacidosis, then she never would have taken the drug. At no point in time was she or her physician warned of Invokana ketoacidosis, nor was it stated on the drug’s warning label.
Luana claims that the company’s willful or negligent failure of providing adequate warnings, had resulted in her developing the permanent complication. Due to this condition, Luana’s life is permanently altered and will need to take a variety of new medications to adjust to the additional symptoms.
The charges in Luana’s Invokana lawsuit include: negligence, false advertising, concealing information, and misrepresenting a product.
Overview of Invokana Ketoacidosis Complications
Invokana is one of Johnson & Johnson’s best selling medications, with sales totaling $278 million in the first quarter of 2015 alone.
The drug was first approved by the FDA in March 2013, to be a treatment option for patients with type-2 diabetes. Invokana is apart of the sodium-glucose contransporter two (SGLT2) inhibitor drug class, and is the first drug in its class to receive FDA approval.
SGLT2 inhibitors are designed to inhibit renal glucose reabsorption, which ultimately lowers blood glucose levels. This prevents excess glucose from being metabolized, and is the ejected from the body through urination.
Ideally this medication would allow patients live healthy and active lifestyles, yet the number of Invokana ketoacidosis complaints have caused major concern. As mentioned before, ketoacidosis occurs when the body becomes unable to produce insulin.
This hormone is vital in converting food and nutrients into energy from the body, along with being an important role in the patient’s metabolism. According to the FDA adverse event database, Invokana patients are several times more likely to develop ketoacidosis that taking diabetes drugs from different drug classes.
Despite allegedly knowing of this risk, Johnson & Johnson and its subsidiaries allegedly chose to omit this information from Invokana’s warning label. Patients who developed this condition, may be eligible for an Invokana lawsuit and should consult an attorney.
This Invokana lawsuit is Luana C. v. Johnson & Johnson, Case No. 1:15-cv-00636, in the U.S. District Court of Southern Alabama, Southern Division.
In general, diabetes medication lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or class action lawsuit is best for you. Hurry — statutes of limitations may apply.
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2016 Top Class Actions® LLC
Various Trademarks held by their respective owners
Get Help – It’s Free
Join a Free Diabetes Medication Class Action Lawsuit Investigation
If you or a loved one suffered ketoacidosis or kidney failure after taking Invokana, Invokamet, Farxiga, Xigduo XR, Jardiance or Glyxambi, you may have a legal claim. See if you qualify to pursue compensation and join a free diabetes medication class action lawsuit investigation by submitting your information for a free case evaluation.
An attorney will contact you if you qualify to discuss the details of your potential case.
- First Name*
- Last Name*
- Street Address*
- Apt. #
- City*
- State*
AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific
- Zip Code*
- Phone*
- Email*
- Please select the diabetes medication(s) you have taken:*
-
Invokana (canagliflozin)
-
Invokamet (canagliflozin and metformin)
-
Farxiga (dapagliflozin)
-
Xigduo XR (dapagliflozin and metformin extended-release)
-
Jardiance (empaglifloziin)
-
Glyxambi (empagliflozin and linagliptin)
-
- When did you take the diabetes medication(s)?*
- Please select the symptoms you or your loved one were medically diagnosed with:*
-
Ketoacidosis
-
Kidney Failure
-
Not Listed (please detail the symptoms in the comments section if this is selected)
-
No diagnosis/injury
-
- ¿Necesita un orador español?
- Yes
- No
- Please enter any additional details you would like the staff reviewing your submission to know.*
- I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared.*
-
Yes
-
-
if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 144) {gformInitChosenFields(‘#input_144_5′,’No results matched’);if(!/(android)/i.test(navigator.userAgent)){jQuery(‘#input_144_7’).mask(‘(999) 999-9999’).bind(‘keypress’, function(e){if(e.which == 13){jQuery(this).blur();} } );}} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_144_5′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [144, 1]) } );
The post Alabama Woman sues Johnson & Johnson over Invokana Ketoacidosis appeared first on Top Class Actions.
Thank you for your so cool post, it is useful, I love it very much. Please share with us more good articles.
ReplyDeleteInvokana lawsuit